Crispr Therapeutics shares owned by ProFund Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by ProFund Advisors
from 13F filings
Historical chart of ProFund Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by ProFund Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.2M | 33k | 64.81 |
| 2025-06-30 | $1.2M | 24k | 48.64 |
| 2025-03-31 | $984k | 29k | 34.03 |
| 2024-12-31 | $1.2M | 30k | 39.36 |
| 2024-09-30 | $1.9M | 41k | 46.98 |
| 2024-06-30 | $1.8M | 32k | 54.01 |
| 2024-03-31 | $1.2M | 18k | 68.16 |
| 2023-09-30 | $1.3M | 29k | 45.39 |
| 2023-06-30 | $1.4M | 24k | 56.14 |
| 2023-03-31 | $1.3M | 29k | 45.23 |
| 2022-12-31 | $355k | 8.7k | 40.65 |
| 2022-09-30 | $556k | 8.5k | 65.37 |
| 2022-06-30 | $495k | 8.1k | 60.80 |
| 2022-03-31 | $551k | 8.8k | 62.82 |